Abstract:TMEM16F is involved in many physiological processes such as blood coagulation, cell membrane fusion and bone mineralization. Activation of TMEM16F has been studied in various central nervous system diseases. High TMEM16F level has been also found to participate in microglial phagocytosis and transformation. Microglia-mediated neuroinflammation is a key factor in promoting the progression of Alzheimer's disease. However, few studies have examined the effects of TMEM16F on neuroinflammation in Alzheimer's disease. In this study, we established TMEM16F-knockdown AD model in vitro and in vivo to investigate the underlying regulatory mechanism about TMEM16F-mediated neuroinflammation in AD. We performed a Morris water maze test to evaluate the spatial memory ability of animals and detected markers for the microglia M1/M2 phenotype and NLRP3 inflammasome. Our results showed that TMEM16F was elevated in 9-month-old APP/PS1 mice. After TMEM16F knockdown in mice, spatial memory ability was improved, microglia polarization to the M2 phenotype was promoted, NLRP3 inflammasome activation was inhibited, cell apoptosis and Aβ plaque deposition in brain tissue were reduced, and brain injury was alleviated. We used amyloid-beta (Aβ<sub>25-35</sub>) to stimulate human microglia to construct microglia models of Alzheimer's disease. The levels of TMEM16F, inducible nitric oxide synthase (iNOS), proinflammatory cytokines and NLRP3 inflammasome-associated biomarkers were higher in Aβ<sub>25-35</sub> treated group compared with that in the control group. TMEM16F knockdown enhanced the expression of the M2 phenotype biomarkers Arg1 and Socs3, reduced the release of proinflammatory factors interleukin-1, interleukin-6 and tumor necrosis factor-α, and inhibited NLRP3 inflammasome activation through reducing downstream proinflammatory factors interleukin-1β and interleukin-18. This inhibitory effect of TMEM16F knockdown on M1 microglia was partially reversed by the NLRP3 agonist Nigericin. Our findings suggest that TMEM16F participates in neuroinflammation in Alzheimer's disease through participating in polarization of microglia and activation of the NLRP3 inflammasome. These results indicate that TMEM16F inhibition may be a potential therapeutic approach for Alzheimer's disease treatment.

TMEM25 Modulates Neuronal Excitability and NMDA Receptor Subunit NR2B Degradation.

TMEM175: A Lysosomal Ion Channel Associated with Neurological Diseases

Transient Receptor Potential Melastatin 2 Contributes to Neuroinflammation and Negatively Regulates Cognitive Outcomes in a Pilocarpine-Induced Mouse Model of Epilepsy.

Transmembrane protein modulates seizure in epilepsy: evidence from temporal lobe epilepsy patients and mouse models

<i>Trpm2</i> deficiency in microglia attenuates neuroinflammation during epileptogenesis by upregulating autophagy via the AMPK/mTOR pathway

The Neuron-Specific Protein TMEM59L Mediates Oxidative Stress-Induced Cell Death.

TMEM16F may be a new therapeutic target for Alzheimer’s disease

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility

The identification of the key residues E829 and R845 involved in transient receptor potential melastatin 2 channel gating

A Purinergic P2 Receptor Family-Mediated Increase in Thrombospondin-1 Bolsters Synaptic Density and Epileptic Seizure Activity in the Amygdala-Kindling Rat Model

Opposing Roles of Transient and Prolonged Expression of P25 in Synaptic Plasticity and Hippocampus-Dependent Memory.

TRPM2 ion channel is involved in the aggravation of cognitive impairment and down regulation of epilepsy threshold in pentylenetetrazole-induced kindling mice

Alleviating symptoms of neurodegenerative disorders by astrocyte-specific overexpression of TMEM164 in mice

Neural-specific distribution of transmembrane protein TMEM240 and formation of TMEM240-Body

MBD5 regulates NMDA receptor expression and seizures by inhibiting Stat1 transcription

TMEM59 Interacts with TREM2 and Modulates TREM2-dependent Microglial Activities

STK24 Modulates Excitatory Synaptic Transmission in Epileptic Hippocampal Neurons

Physiological and pathological functions of TMEM106B in neurodegenerative diseases

TMEM100, A Regulator Of TRPA1-TRPV1 Interaction, Contributes To Temporomandibular Disorder Pain In Mice

Pain-causing Stinging Nettle Toxins Target TMEM233 to Modulate NaV1.7 Function.

Disruption of Tmem30a Results in Cerebellar Ataxia and Degeneration of Purkinje Cells